Articles written by: Fred Herman

Comparing of Aclaris Therapeutics Inc. (ACRS) and Citius Pharmaceuticals Inc. (NASDAQ:CTXR)

Since Aclaris Therapeutics Inc. (NASDAQ:ACRS) and Citius Pharmaceuticals Inc. (NASDAQ:CTXR) are part of the Biotechnology industry, they are influenced by contrast. The influences particularly affect the risk, analyst recommendations, institutional ownership, profitability, dividends, earnings and valuation of both companies. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per […]

Reviewing AnaptysBio Inc. (ANAB)’s and Neon Therapeutics Inc. (NASDAQ:NTGN)’s results

AnaptysBio Inc. (NASDAQ:ANAB) and Neon Therapeutics Inc. (NASDAQ:NTGN), both competing one another are Biotechnology companies. We will contrast their profitability, analyst recommendations, institutional ownership, risk, dividends, earnings and valuation. Valuation and Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio AnaptysBio Inc. 30 0.00 20.06M -2.68 0.00 […]

Contrasting of Neonode Inc. (NEON) and O2Micro International Limited (NASDAQ:OIIM)

This is therefore a contrasting of the risk, analyst recommendations, profitability, dividends, institutional ownership, earnings and valuation in Neonode Inc. (NASDAQ:NEON) and O2Micro International Limited (NASDAQ:OIIM). The two are both Diversified Electronics companies that compete with one another. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share […]

Comparing of Artelo Biosciences Inc. (ARTL) and Marker Therapeutics Inc. (NASDAQ:MRKR)

Artelo Biosciences Inc. (NASDAQ:ARTL) and Marker Therapeutics Inc. (NASDAQ:MRKR) are two firms in the Biotechnology that compete against each other. Below is a comparison of their profitability, institutional ownership, analyst recommendations, risk, dividends, earnings and valuation. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio […]

Nuveen High Income 2020 Target Term Fund (JHY)’s Financial Results Comparing With Wells Fargo Advantage Utilities and High Income Fund (NYSE:ERH)

Nuveen High Income 2020 Target Term Fund (NYSE:JHY) and Wells Fargo Advantage Utilities and High Income Fund (NYSE:ERH) compete with each other in the Asset Management sector. We will analyze and contrast their analyst recommendations, profitability, risk, dividends, institutional ownership, earnings and valuation. Earnings and Valuation Gross Revenue Price/Sales Ratio […]

Benitec Biopharma Limited (BNTC)’s Financial Results Comparing With MannKind Corporation (NASDAQ:MNKD)

Benitec Biopharma Limited (NASDAQ:BNTC) and MannKind Corporation (NASDAQ:MNKD) are two firms in the Biotechnology that compete against each other. Below is a comparison of their profitability, analyst recommendations, risk, dividends, institutional ownership, earnings and valuation. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Benitec […]

Seelos Therapeutics Inc. (SEEL)’s Financial Results Comparing With Zogenix Inc. (NASDAQ:ZGNX)

This is a contrast between Seelos Therapeutics Inc. (NASDAQ:SEEL) and Zogenix Inc. (NASDAQ:ZGNX) based on their profitability, analyst recommendations, risk, dividends, institutional ownership, earnings and valuation. The two companies are Biotechnology and they also compete with each other. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share […]

MorphoSys AG (MOR)’s Financial Results Comparing With Affimed N.V. (NASDAQ:AFMD)

MorphoSys AG (NASDAQ:MOR) and Affimed N.V. (NASDAQ:AFMD) compete against each other in the Biotechnology sector. We will compare them and contrast their profitability, analyst recommendations, institutional ownership, risk, dividends, earnings and valuation. Valuation & Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio MorphoSys AG 27 0.00 […]